PD-L1 as a biomarker in NSCLC: challenges and future directions

Ann Transl Med. 2017 Sep;5(18):375. doi: 10.21037/atm.2017.08.04.

Authors

Matthen Mathew¹, Rachael A Safyan¹, Catherine A Shu¹

Affiliation

¹ Division of Hematology and Oncology, Columbia University Medical Center, New York, NY, USA.

No abstract available

Publication types

Editorial